Skip to main content
. 2023 Feb 9;24(4):3465. doi: 10.3390/ijms24043465

Table 1.

Number of animals used in each experimental group.

Figure Group Total
Number of Animals Used
Sample Size Number of Animals
Excluded 1
Figure 1B Butoxamine
concentration (mg/kg)
Control 0 16 14 2
30 6 6 0
AcGP 0 18 18 0
3 4 4 0
10 8 7 1
30 9 9 0
Figure 1C Carazolol
concentration (mg/kg)
Control 0 12 12 0
10 8 8 0
AcGP 0 12 12 0
0.3 8 8 0
1 8 8 0
10 8 8 0
Figure 1E Butoxamine
concentration (mg/kg)
Control 0 5 5 0
30 6 6 0
AcGP 0 5 5 0
30 6 6 0
Figure 1F Carazolol
concentration (mg/kg)
Control 0 6 6 0
10 7 6 1
AcGP 0 6 6 0
10 6 6 0
Figure 2A Prazosin
concentration
(mg/kg)
Control 0 8 8 0
10 8 8 0
AcGP 0 8 8 0
1 4 4 0
10 8 8 0
Figure 2B Butylscopolamine concentration
(mg/kg)
Control 0 8 8 0
15 4 4 0
AcGP 0 8 8 0
5 4 4 0
15 4 4 0
Figure 3B Butoxamine
concentration (mg/kg)
Control 0 8 8 0
30 8 8 0
AcGP 0 8 8 0
30 9 8 1
Figure 3C Prazosin
concentration
(mg/kg)
Control 0 7 7 0
10 8 8 0
AcGP 0 8 8 0
10 8 8 0

1 Animals which died at the time of drug injection or anesthesia were excluded.